Microbira delivering a lecture on AI Innovation at System C, February 2024
Watch Marianne Ismail, CEO of Microbira, as she explores how AI innovation rapidly detects and identifies infectious microorganisms during her lecture at System C. She highlights how Microbira leverages artificial intelligence (AI) and Fourier Transform Infrared (FTIR) spectroscopy to transform healthcare diagnostics. This innovative approach marks a significant shift in the way infectious diseases are identified and managed.
Introducing MAAP-IR
Microbira is revolutionising healthcare delivery with its cutting-edge Microbira Advanced Analytical Platform – Infrared (MAAP-IR). This AI-driven platform offers a seamless solution for microorganism identification, suitable for clinical microbiology laboratories of all sizes. Furthermore, MAAP-IR can rapidly identify over 20 clinically relevant species, including Escherichia coli, Staphylococcus aureus, and Candida auris, in less than five minutes. Such rapid identification enables clinicians to act quickly and accurately, improving patient care outcomes significantly.
One of the key advantages of MAAP-IR lies in its reagent-free and cost-effective approach. This makes microbial identification not only efficient but also highly accessible to a broad range of healthcare providers. Moreover, the platform utilises advanced cloud-based AI technology and digital health applications to deliver precise and reliable results. The comprehensive spectral databases and proprietary algorithms optimise both accuracy and speed, setting a new benchmark for diagnostic tools.
Driving Innovation
Microbira’s commitment to AI innovation goes beyond technology. By empowering clinicians with rapid diagnostic solutions, the company helps reduce delays in treatment, thereby improving patient outcomes and enhancing overall healthcare delivery. Microbira also actively contributes to global public health efforts by developing tools that address antimicrobial resistance and other critical healthcare challenges.
As Microbira continues to innovate, it remains dedicated to delivering high-impact diagnostic tools that are both affordable and effective. These tools not only benefit healthcare providers but also ultimately improve the lives of patients worldwide.